According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Recombinant Human Chorionic Gonadotropin - Market

The global market for Recombinant Human Chorionic Gonadotropin was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Recombinant Human Chorionic Gonadotropin, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Recombinant Human Chorionic Gonadotropin by region & country, by Type, and by Application.

The Recombinant Human Chorionic Gonadotropin market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human Chorionic Gonadotropin.

Market Segmentation

Scope of Recombinant Human Chorionic Gonadotropin - Market Report

Report Metric	Details
Report Name	Recombinant Human Chorionic Gonadotropin - Market
Accounted market size in year	US$ 603 billion
CAGR	5%
Base Year	year
Segment by Type:	Intramuscular Powder for Injection Subcutaneous Solution for Injection
Segment by Application	Female Male
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Ferring Pharmaceuticals, Schering Plough, Serum International Ltd, Merck, Wellona Pharma, Bionomics Lifesciences, Marvel Oceanic Private Limited, Facmed Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Recombinant Human Chorionic Gonadotropin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Recombinant Human Chorionic Gonadotropin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Recombinant Human Chorionic Gonadotropin in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Recombinant Human Chorionic Gonadotropin - Market report?

Ans: The main players in the Recombinant Human Chorionic Gonadotropin - Market are Ferring Pharmaceuticals, Schering Plough, Serum International Ltd, Merck, Wellona Pharma, Bionomics Lifesciences, Marvel Oceanic Private Limited, Facmed Pharmaceuticals

What are the Application segmentation covered in the Recombinant Human Chorionic Gonadotropin - Market report?

Ans: The Applications covered in the Recombinant Human Chorionic Gonadotropin - Market report are Female, Male

What are the Type segmentation covered in the Recombinant Human Chorionic Gonadotropin - Market report?

Ans: The Types covered in the Recombinant Human Chorionic Gonadotropin - Market report are Intramuscular Powder for Injection, Subcutaneous Solution for Injection

1 Market Overview

1.1 Recombinant Human Chorionic Gonadotropin Product Introduction

1.2 Global Recombinant Human Chorionic Gonadotropin Market Size Forecast

1.2.1 Global Recombinant Human Chorionic Gonadotropin Sales Value (2019-2030)

1.2.2 Global Recombinant Human Chorionic Gonadotropin Sales Volume (2019-2030)

1.2.3 Global Recombinant Human Chorionic Gonadotropin Sales Price (2019-2030)

1.3 Recombinant Human Chorionic Gonadotropin Market Trends & Drivers

1.3.1 Recombinant Human Chorionic Gonadotropin Industry Trends

1.3.2 Recombinant Human Chorionic Gonadotropin Market Drivers & Opportunity

1.3.3 Recombinant Human Chorionic Gonadotropin Market Challenges

1.3.4 Recombinant Human Chorionic Gonadotropin Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Recombinant Human Chorionic Gonadotropin Players Revenue Ranking (2023)

2.2 Global Recombinant Human Chorionic Gonadotropin Revenue by Company (2019-2024)

2.3 Global Recombinant Human Chorionic Gonadotropin Players Sales Volume Ranking (2023)

2.4 Global Recombinant Human Chorionic Gonadotropin Sales Volume by Company Players (2019-2024)

2.5 Global Recombinant Human Chorionic Gonadotropin Average Price by Company (2019-2024)

2.6 Key Manufacturers Recombinant Human Chorionic Gonadotropin Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Recombinant Human Chorionic Gonadotropin Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Recombinant Human Chorionic Gonadotropin

2.9 Recombinant Human Chorionic Gonadotropin Market Competitive Analysis

2.9.1 Recombinant Human Chorionic Gonadotropin Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Recombinant Human Chorionic Gonadotropin Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Chorionic Gonadotropin as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Intramuscular Powder for Injection

3.1.2 Subcutaneous Solution for Injection

3.2 Global Recombinant Human Chorionic Gonadotropin Sales Value by Type

3.2.1 Global Recombinant Human Chorionic Gonadotropin Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Recombinant Human Chorionic Gonadotropin Sales Value, by Type (2019-2030)

3.2.3 Global Recombinant Human Chorionic Gonadotropin Sales Value, by Type (%) (2019-2030)

3.3 Global Recombinant Human Chorionic Gonadotropin Sales Volume by Type

3.3.1 Global Recombinant Human Chorionic Gonadotropin Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Recombinant Human Chorionic Gonadotropin Sales Volume, by Type (2019-2030)

3.3.3 Global Recombinant Human Chorionic Gonadotropin Sales Volume, by Type (%) (2019-2030)

3.4 Global Recombinant Human Chorionic Gonadotropin Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Female

4.1.2 Male

4.2 Global Recombinant Human Chorionic Gonadotropin Sales Value by Application

4.2.1 Global Recombinant Human Chorionic Gonadotropin Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Recombinant Human Chorionic Gonadotropin Sales Value, by Application (2019-2030)

4.2.3 Global Recombinant Human Chorionic Gonadotropin Sales Value, by Application (%) (2019-2030)

4.3 Global Recombinant Human Chorionic Gonadotropin Sales Volume by Application

4.3.1 Global Recombinant Human Chorionic Gonadotropin Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Recombinant Human Chorionic Gonadotropin Sales Volume, by Application (2019-2030)

4.3.3 Global Recombinant Human Chorionic Gonadotropin Sales Volume, by Application (%) (2019-2030)

4.4 Global Recombinant Human Chorionic Gonadotropin Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Recombinant Human Chorionic Gonadotropin Sales Value by Region

5.1.1 Global Recombinant Human Chorionic Gonadotropin Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Recombinant Human Chorionic Gonadotropin Sales Value by Region (2019-2024)

5.1.3 Global Recombinant Human Chorionic Gonadotropin Sales Value by Region (2025-2030)

5.1.4 Global Recombinant Human Chorionic Gonadotropin Sales Value by Region (%), (2019-2030)

5.2 Global Recombinant Human Chorionic Gonadotropin Sales Volume by Region

5.2.1 Global Recombinant Human Chorionic Gonadotropin Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Recombinant Human Chorionic Gonadotropin Sales Volume by Region (2019-2024)

5.2.3 Global Recombinant Human Chorionic Gonadotropin Sales Volume by Region (2025-2030)

5.2.4 Global Recombinant Human Chorionic Gonadotropin Sales Volume by Region (%), (2019-2030)

5.3 Global Recombinant Human Chorionic Gonadotropin Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Recombinant Human Chorionic Gonadotropin Sales Value, 2019-2030

5.4.2 North America Recombinant Human Chorionic Gonadotropin Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Recombinant Human Chorionic Gonadotropin Sales Value, 2019-2030

5.5.2 Europe Recombinant Human Chorionic Gonadotropin Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Recombinant Human Chorionic Gonadotropin Sales Value, 2019-2030

5.6.2 Asia Pacific Recombinant Human Chorionic Gonadotropin Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Recombinant Human Chorionic Gonadotropin Sales Value, 2019-2030

5.7.2 South America Recombinant Human Chorionic Gonadotropin Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Recombinant Human Chorionic Gonadotropin Sales Value, 2019-2030

5.8.2 Middle East & Africa Recombinant Human Chorionic Gonadotropin Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Recombinant Human Chorionic Gonadotropin Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Recombinant Human Chorionic Gonadotropin Sales Value

6.2.1 Key Countries/Regions Recombinant Human Chorionic Gonadotropin Sales Value, 2019-2030

6.2.2 Key Countries/Regions Recombinant Human Chorionic Gonadotropin Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Recombinant Human Chorionic Gonadotropin Sales Value, 2019-2030

6.3.2 United States Recombinant Human Chorionic Gonadotropin Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Recombinant Human Chorionic Gonadotropin Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Recombinant Human Chorionic Gonadotropin Sales Value, 2019-2030

6.4.2 Europe Recombinant Human Chorionic Gonadotropin Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Recombinant Human Chorionic Gonadotropin Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Recombinant Human Chorionic Gonadotropin Sales Value, 2019-2030

6.5.2 China Recombinant Human Chorionic Gonadotropin Sales Value by Type (%), 2023 VS 2030

6.5.3 China Recombinant Human Chorionic Gonadotropin Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Recombinant Human Chorionic Gonadotropin Sales Value, 2019-2030

6.6.2 Japan Recombinant Human Chorionic Gonadotropin Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Recombinant Human Chorionic Gonadotropin Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Recombinant Human Chorionic Gonadotropin Sales Value, 2019-2030

6.7.2 South Korea Recombinant Human Chorionic Gonadotropin Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Recombinant Human Chorionic Gonadotropin Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Recombinant Human Chorionic Gonadotropin Sales Value, 2019-2030

6.8.2 Southeast Asia Recombinant Human Chorionic Gonadotropin Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Recombinant Human Chorionic Gonadotropin Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Recombinant Human Chorionic Gonadotropin Sales Value, 2019-2030

6.9.2 India Recombinant Human Chorionic Gonadotropin Sales Value by Type (%), 2023 VS 2030

6.9.3 India Recombinant Human Chorionic Gonadotropin Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Ferring Pharmaceuticals

7.1.1 Ferring Pharmaceuticals Company Information

7.1.2 Ferring Pharmaceuticals Introduction and Business Overview

7.1.3 Ferring Pharmaceuticals Recombinant Human Chorionic Gonadotropin Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Ferring Pharmaceuticals Recombinant Human Chorionic Gonadotropin Product Offerings

7.1.5 Ferring Pharmaceuticals Recent Development

7.2 Schering Plough

7.2.1 Schering Plough Company Information

7.2.2 Schering Plough Introduction and Business Overview

7.2.3 Schering Plough Recombinant Human Chorionic Gonadotropin Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Schering Plough Recombinant Human Chorionic Gonadotropin Product Offerings

7.2.5 Schering Plough Recent Development

7.3 Serum International Ltd

7.3.1 Serum International Ltd Company Information

7.3.2 Serum International Ltd Introduction and Business Overview

7.3.3 Serum International Ltd Recombinant Human Chorionic Gonadotropin Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Serum International Ltd Recombinant Human Chorionic Gonadotropin Product Offerings

7.3.5 Serum International Ltd Recent Development

7.4 Merck

7.4.1 Merck Company Information

7.4.2 Merck Introduction and Business Overview

7.4.3 Merck Recombinant Human Chorionic Gonadotropin Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Merck Recombinant Human Chorionic Gonadotropin Product Offerings

7.4.5 Merck Recent Development

7.5 Wellona Pharma

7.5.1 Wellona Pharma Company Information

7.5.2 Wellona Pharma Introduction and Business Overview

7.5.3 Wellona Pharma Recombinant Human Chorionic Gonadotropin Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Wellona Pharma Recombinant Human Chorionic Gonadotropin Product Offerings

7.5.5 Wellona Pharma Recent Development

7.6 Bionomics Lifesciences

7.6.1 Bionomics Lifesciences Company Information

7.6.2 Bionomics Lifesciences Introduction and Business Overview

7.6.3 Bionomics Lifesciences Recombinant Human Chorionic Gonadotropin Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Bionomics Lifesciences Recombinant Human Chorionic Gonadotropin Product Offerings

7.6.5 Bionomics Lifesciences Recent Development

7.7 Marvel Oceanic Private Limited

7.7.1 Marvel Oceanic Private Limited Company Information

7.7.2 Marvel Oceanic Private Limited Introduction and Business Overview

7.7.3 Marvel Oceanic Private Limited Recombinant Human Chorionic Gonadotropin Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Marvel Oceanic Private Limited Recombinant Human Chorionic Gonadotropin Product Offerings

7.7.5 Marvel Oceanic Private Limited Recent Development

7.8 Facmed Pharmaceuticals

7.8.1 Facmed Pharmaceuticals Company Information

7.8.2 Facmed Pharmaceuticals Introduction and Business Overview

7.8.3 Facmed Pharmaceuticals Recombinant Human Chorionic Gonadotropin Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Facmed Pharmaceuticals Recombinant Human Chorionic Gonadotropin Product Offerings

7.8.5 Facmed Pharmaceuticals Recent Development

8 Industry Chain Analysis

8.1 Recombinant Human Chorionic Gonadotropin Industrial Chain

8.2 Recombinant Human Chorionic Gonadotropin Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Recombinant Human Chorionic Gonadotropin Sales Model

8.5.2 Sales Channel

8.5.3 Recombinant Human Chorionic Gonadotropin Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Ferring Pharmaceuticals

Schering Plough

Merck

Wellona Pharma

Facmed Pharmaceuticals

Serum International Ltd

Bionomics Lifesciences

Marvel Oceanic Private Limited

List of Tables

Table 1. Recombinant Human Chorionic Gonadotropin Market Trends

Table 2. Recombinant Human Chorionic Gonadotropin Market Drivers & Opportunity

Table 3. Recombinant Human Chorionic Gonadotropin Market Challenges

Table 4. Recombinant Human Chorionic Gonadotropin Market Restraints

Table 5. Global Recombinant Human Chorionic Gonadotropin Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Recombinant Human Chorionic Gonadotropin Revenue Market Share by Company (2019-2024)

Table 7. Global Recombinant Human Chorionic Gonadotropin Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Recombinant Human Chorionic Gonadotropin Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Recombinant Human Chorionic Gonadotropin Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Recombinant Human Chorionic Gonadotropin Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Recombinant Human Chorionic Gonadotropin Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Recombinant Human Chorionic Gonadotropin

Table 13. Global Recombinant Human Chorionic Gonadotropin Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Chorionic Gonadotropin as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Recombinant Human Chorionic Gonadotropin Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Recombinant Human Chorionic Gonadotropin Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Recombinant Human Chorionic Gonadotropin Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Recombinant Human Chorionic Gonadotropin Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Recombinant Human Chorionic Gonadotropin Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Recombinant Human Chorionic Gonadotropin Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Recombinant Human Chorionic Gonadotropin Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Recombinant Human Chorionic Gonadotropin Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Recombinant Human Chorionic Gonadotropin Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Recombinant Human Chorionic Gonadotropin Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Recombinant Human Chorionic Gonadotropin Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Recombinant Human Chorionic Gonadotropin Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Recombinant Human Chorionic Gonadotropin Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Recombinant Human Chorionic Gonadotropin Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Recombinant Human Chorionic Gonadotropin Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Recombinant Human Chorionic Gonadotropin Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Recombinant Human Chorionic Gonadotropin Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Recombinant Human Chorionic Gonadotropin Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Recombinant Human Chorionic Gonadotropin Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Recombinant Human Chorionic Gonadotropin Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Recombinant Human Chorionic Gonadotropin Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Recombinant Human Chorionic Gonadotropin Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Recombinant Human Chorionic Gonadotropin Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Recombinant Human Chorionic Gonadotropin Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Recombinant Human Chorionic Gonadotropin Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Recombinant Human Chorionic Gonadotropin Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Recombinant Human Chorionic Gonadotropin Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Recombinant Human Chorionic Gonadotropin Sales Value by Region (2019-2024) & (%)

Table 44. Global Recombinant Human Chorionic Gonadotropin Sales Value by Region (2025-2030) & (%)

Table 45. Global Recombinant Human Chorionic Gonadotropin Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Recombinant Human Chorionic Gonadotropin Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Recombinant Human Chorionic Gonadotropin Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Recombinant Human Chorionic Gonadotropin Sales Volume by Region (2019-2024) & (%)

Table 49. Global Recombinant Human Chorionic Gonadotropin Sales Volume by Region (2025-2030) & (%)

Table 50. Global Recombinant Human Chorionic Gonadotropin Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Recombinant Human Chorionic Gonadotropin Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Recombinant Human Chorionic Gonadotropin Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Recombinant Human Chorionic Gonadotropin Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Recombinant Human Chorionic Gonadotropin Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Recombinant Human Chorionic Gonadotropin Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Recombinant Human Chorionic Gonadotropin Sales Volume, (2025-2030) & (K Units)

Table 57. Ferring Pharmaceuticals Company Information

Table 58. Ferring Pharmaceuticals Introduction and Business Overview

Table 59. Ferring Pharmaceuticals Recombinant Human Chorionic Gonadotropin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Ferring Pharmaceuticals Recombinant Human Chorionic Gonadotropin Product Offerings

Table 61. Ferring Pharmaceuticals Recent Development

Table 62. Schering Plough Company Information

Table 63. Schering Plough Introduction and Business Overview

Table 64. Schering Plough Recombinant Human Chorionic Gonadotropin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Schering Plough Recombinant Human Chorionic Gonadotropin Product Offerings

Table 66. Schering Plough Recent Development

Table 67. Serum International Ltd Company Information

Table 68. Serum International Ltd Introduction and Business Overview

Table 69. Serum International Ltd Recombinant Human Chorionic Gonadotropin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. Serum International Ltd Recombinant Human Chorionic Gonadotropin Product Offerings

Table 71. Serum International Ltd Recent Development

Table 72. Merck Company Information

Table 73. Merck Introduction and Business Overview

Table 74. Merck Recombinant Human Chorionic Gonadotropin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. Merck Recombinant Human Chorionic Gonadotropin Product Offerings

Table 76. Merck Recent Development

Table 77. Wellona Pharma Company Information

Table 78. Wellona Pharma Introduction and Business Overview

Table 79. Wellona Pharma Recombinant Human Chorionic Gonadotropin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Wellona Pharma Recombinant Human Chorionic Gonadotropin Product Offerings

Table 81. Wellona Pharma Recent Development

Table 82. Bionomics Lifesciences Company Information

Table 83. Bionomics Lifesciences Introduction and Business Overview

Table 84. Bionomics Lifesciences Recombinant Human Chorionic Gonadotropin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Bionomics Lifesciences Recombinant Human Chorionic Gonadotropin Product Offerings

Table 86. Bionomics Lifesciences Recent Development

Table 87. Marvel Oceanic Private Limited Company Information

Table 88. Marvel Oceanic Private Limited Introduction and Business Overview

Table 89. Marvel Oceanic Private Limited Recombinant Human Chorionic Gonadotropin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. Marvel Oceanic Private Limited Recombinant Human Chorionic Gonadotropin Product Offerings

Table 91. Marvel Oceanic Private Limited Recent Development

Table 92. Facmed Pharmaceuticals Company Information

Table 93. Facmed Pharmaceuticals Introduction and Business Overview

Table 94. Facmed Pharmaceuticals Recombinant Human Chorionic Gonadotropin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. Facmed Pharmaceuticals Recombinant Human Chorionic Gonadotropin Product Offerings

Table 96. Facmed Pharmaceuticals Recent Development

Table 97. Key Raw Materials Lists

Table 98. Raw Materials Key Suppliers Lists

Table 99. Recombinant Human Chorionic Gonadotropin Downstream Customers

Table 100. Recombinant Human Chorionic Gonadotropin Distributors List

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

List of Figures

Figure 1. Recombinant Human Chorionic Gonadotropin Product Picture

Figure 2. Global Recombinant Human Chorionic Gonadotropin Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Recombinant Human Chorionic Gonadotropin Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Recombinant Human Chorionic Gonadotropin Sales Volume (2019-2030) & (K Units)

Figure 5. Global Recombinant Human Chorionic Gonadotropin Sales Price (2019-2030) & (US$/Unit)

Figure 6. Recombinant Human Chorionic Gonadotropin Report Years Considered

Figure 7. Global Recombinant Human Chorionic Gonadotropin Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Recombinant Human Chorionic Gonadotropin Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Recombinant Human Chorionic Gonadotropin Revenue in 2023

Figure 10. Recombinant Human Chorionic Gonadotropin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Intramuscular Powder for Injection Picture

Figure 12. Subcutaneous Solution for Injection Picture

Figure 13. Global Recombinant Human Chorionic Gonadotropin Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Recombinant Human Chorionic Gonadotropin Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Recombinant Human Chorionic Gonadotropin Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Recombinant Human Chorionic Gonadotropin Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Recombinant Human Chorionic Gonadotropin Price by Type (2019-2030) & (US$/Unit)

Figure 18. Product Picture of Female

Figure 19. Product Picture of Male

Figure 20. Global Recombinant Human Chorionic Gonadotropin Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 21. Global Recombinant Human Chorionic Gonadotropin Sales Value Market Share by Application, 2023 & 2030

Figure 22. Global Recombinant Human Chorionic Gonadotropin Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 23. Global Recombinant Human Chorionic Gonadotropin Sales Volume Market Share by Application, 2023 & 2030

Figure 24. Global Recombinant Human Chorionic Gonadotropin Price by Application (2019-2030) & (US$/Unit)

Figure 25. North America Recombinant Human Chorionic Gonadotropin Sales Value (2019-2030) & (US$ Million)

Figure 26. North America Recombinant Human Chorionic Gonadotropin Sales Value by Country (%), 2023 VS 2030

Figure 27. Europe Recombinant Human Chorionic Gonadotropin Sales Value (2019-2030) & (US$ Million)

Figure 28. Europe Recombinant Human Chorionic Gonadotropin Sales Value by Country (%), 2023 VS 2030

Figure 29. Asia Pacific Recombinant Human Chorionic Gonadotropin Sales Value (2019-2030) & (US$ Million)

Figure 30. Asia Pacific Recombinant Human Chorionic Gonadotropin Sales Value by Country (%), 2023 VS 2030

Figure 31. South America Recombinant Human Chorionic Gonadotropin Sales Value (2019-2030) & (US$ Million)

Figure 32. South America Recombinant Human Chorionic Gonadotropin Sales Value by Country (%), 2023 VS 2030

Figure 33. Middle East & Africa Recombinant Human Chorionic Gonadotropin Sales Value (2019-2030) & (US$ Million)

Figure 34. Middle East & Africa Recombinant Human Chorionic Gonadotropin Sales Value by Country (%), 2023 VS 2030

Figure 35. Key Countries/Regions Recombinant Human Chorionic Gonadotropin Sales Value (%), (2019-2030)

Figure 36. Key Countries/Regions Recombinant Human Chorionic Gonadotropin Sales Volume (%), (2019-2030)

Figure 37. United States Recombinant Human Chorionic Gonadotropin Sales Value, (2019-2030) & (US$ Million)

Figure 38. United States Recombinant Human Chorionic Gonadotropin Sales Value by Type (%), 2023 VS 2030

Figure 39. United States Recombinant Human Chorionic Gonadotropin Sales Value by Application (%), 2023 VS 2030

Figure 40. Europe Recombinant Human Chorionic Gonadotropin Sales Value, (2019-2030) & (US$ Million)

Figure 41. Europe Recombinant Human Chorionic Gonadotropin Sales Value by Type (%), 2023 VS 2030

Figure 42. Europe Recombinant Human Chorionic Gonadotropin Sales Value by Application (%), 2023 VS 2030

Figure 43. China Recombinant Human Chorionic Gonadotropin Sales Value, (2019-2030) & (US$ Million)

Figure 44. China Recombinant Human Chorionic Gonadotropin Sales Value by Type (%), 2023 VS 2030

Figure 45. China Recombinant Human Chorionic Gonadotropin Sales Value by Application (%), 2023 VS 2030

Figure 46. Japan Recombinant Human Chorionic Gonadotropin Sales Value, (2019-2030) & (US$ Million)

Figure 47. Japan Recombinant Human Chorionic Gonadotropin Sales Value by Type (%), 2023 VS 2030

Figure 48. Japan Recombinant Human Chorionic Gonadotropin Sales Value by Application (%), 2023 VS 2030

Figure 49. South Korea Recombinant Human Chorionic Gonadotropin Sales Value, (2019-2030) & (US$ Million)

Figure 50. South Korea Recombinant Human Chorionic Gonadotropin Sales Value by Type (%), 2023 VS 2030

Figure 51. South Korea Recombinant Human Chorionic Gonadotropin Sales Value by Application (%), 2023 VS 2030

Figure 52. Southeast Asia Recombinant Human Chorionic Gonadotropin Sales Value, (2019-2030) & (US$ Million)

Figure 53. Southeast Asia Recombinant Human Chorionic Gonadotropin Sales Value by Type (%), 2023 VS 2030

Figure 54. Southeast Asia Recombinant Human Chorionic Gonadotropin Sales Value by Application (%), 2023 VS 2030

Figure 55. India Recombinant Human Chorionic Gonadotropin Sales Value, (2019-2030) & (US$ Million)

Figure 56. India Recombinant Human Chorionic Gonadotropin Sales Value by Type (%), 2023 VS 2030

Figure 57. India Recombinant Human Chorionic Gonadotropin Sales Value by Application (%), 2023 VS 2030

Figure 58. Recombinant Human Chorionic Gonadotropin Industrial Chain

Figure 59. Recombinant Human Chorionic Gonadotropin Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions